Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization-Reference-Cited by-同舟云学术

Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization

Published:2023-04 Issue:4 Volume:26 Page:106457
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Pradenas Edwards,Marfil Silvia,Urrea Víctor,Trigueros Macedonia,Pidkova Tetyana,Pons-Grífols Anna,Ortiz Raquel,Rovirosa Carla,Tarrés-Freixas Ferran,Aguilar-Gurrieri Carmen,Toledo Ruth,Chamorro Anna,Noguera-Julian Marc,Mateu Lourdes,Blanco Ignacio,Grau Eulàlia,Massanella Marta,Carrillo Jorge,Clotet Bonaventura,Trinité Benjamin,Blanco Julià

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference60 articles.

1. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa;Viana;Nature,2022

2. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant;Suzuki;Nature,2022

3. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron.;Shuai;Nature,2022

4. Heterogeneous infectivity and pathogenesis of SARS-CoV-2 variants Beta, Delta and omicron in transgenic K18-hACE2 and wildtype mice;Tarrés-Freixas;Front. Microbiol.,2022

5. Clinical update on COVID-19 for the emergency clinician: presentation and evaluation;Long;Am. J. Emerg. Med.,2022

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric antibody responses to SARS-CoV-2 after infection and vaccination in Calgary, Canada;BMC Infectious Diseases;2024-07-18

2. Longitudinal Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 T-Cell Immunity Over 2 Years Following Vaccination and Infection;The Journal of Infectious Diseases;2024-04-30

3. Diminished neutralizing activity against the XBB1.5 strain in 55.9% of individuals post 6 months COVID-19 mRNA booster vaccination: insights from a pseudovirus assay on 1,353 participants in the Fukushima vaccination community survey, Japan;Frontiers in Immunology;2024-03-18

4. Impact of SARS-CoV-2 Vaccine and Infection History on Antiviral Immunity Post Breakthrough Infection;2024

5. Humoral Response Kinetics and Cross-Immunity in Hospitalized Patients with SARS-CoV-2 WT, Delta, or Omicron Infections: A Comparison between Vaccinated and Unvaccinated Cohorts;Vaccines;2023-12-01